PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND APPLICATION THEREOF
A parathyroid hormone 1-34 pharmaceutical composition and a preparation method thereof, specifically relating to a parathyroid hormone 1-34 pharmaceutical composition including parathyroid hormone 1-34 as an active ingredient and a pharmaceutically acceptable vector, the vector at least comprising a buffer liquid, a penetration enhancer, a stabilizer and a preservative. The parathyroid hormone 1-34 pharmaceutical composition is a parathyroid hormone 1-34 nasal spray or nasal spray composition. A parathyroid hormone 1-34 nasal spray or nasal spray composition prepared by means of the present method has the advantages of preventing the first pass effect, leading to high bioavailability; rapid onset of action; and convenient administration, strengthening patient compliance and being absorbed into the nasal mucosa when used, which may effectively reduce the pain of polypeptide drug injection..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Europäisches Patentamt - (2021) vom: 14. Mai Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
ZHENG AIPING [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-05-14, Last update posted on www.tib.eu: 2022-07-02, Last updated: 2023-02-09 |
---|
Patentnummer: |
WO2021088585 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA011677317 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA011677317 | ||
003 | DE-627 | ||
005 | 20230503192518.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210622s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA011677317 | ||
035 | |a (EPA)WO2021088585 | ||
035 | |a (EPA)69335461 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a ZHENG AIPING |e verfasserin |4 aut | |
245 | 1 | 0 | |a PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND APPLICATION THEREOF |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2021-05-14, Last update posted on www.tib.eu: 2022-07-02, Last updated: 2023-02-09 | ||
520 | |a A parathyroid hormone 1-34 pharmaceutical composition and a preparation method thereof, specifically relating to a parathyroid hormone 1-34 pharmaceutical composition including parathyroid hormone 1-34 as an active ingredient and a pharmaceutically acceptable vector, the vector at least comprising a buffer liquid, a penetration enhancer, a stabilizer and a preservative. The parathyroid hormone 1-34 pharmaceutical composition is a parathyroid hormone 1-34 nasal spray or nasal spray composition. A parathyroid hormone 1-34 nasal spray or nasal spray composition prepared by means of the present method has the advantages of preventing the first pass effect, leading to high bioavailability; rapid onset of action; and convenient administration, strengthening patient compliance and being absorbed into the nasal mucosa when used, which may effectively reduce the pain of polypeptide drug injection. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a GAO JING |4 aut | |
700 | 0 | |a WANG DAN |4 aut | |
700 | 0 | |a ZHANG HUI |4 aut | |
700 | 0 | |a DU YIMENG |4 aut | |
700 | 0 | |a SU YUHUAI |4 aut | |
700 | 0 | |a LIU QIAN |4 aut | |
700 | 0 | |a HUA YABING |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 14. Mai |
773 | 1 | 8 | |g year:2021 |g day:14 |g month:05 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/69335461/publication/WO2021088585A1?q=WO2021088585 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2021 |b 14 |c 05 |
951 | |a AR | ||
952 | |j 2021 |b 14 |c 05 |